Elliot Eliyahu Greenblatt1,2, Tilo Winkler2, Robert Scott Harris2, Vanessa Jane Kelly2, Mamary Kone2, Ira Katz3,4, Andrew Martin5,6, George Caillibotte3, Dean R Hess2, Jose G Venegas2. 1. 1 Massachusetts Institute of Technology , Boston, Massachusetts. 2. 2 Massachusetts General Hospital and Harvard Medical School , Boston, Massachusetts. 3. 3 R & D Medical, Air Liquide Santé International , Les-Loges-en-Josas, France . 4. 4 Department of Mechanical Engineering, Lafayette College , Easton, Pennsylvania. 5. 5 Delaware Research and Technology Center , American Air Liquide, Newark, Delaware. 6. 6 Department of Mechanical Engineering, University of Alberta , Edmonton, Alberta, Canada .
Abstract
BACKGROUND: Theoretical models suggest that He-O2 as carrier gas may lead to more homogeneous ventilation and aerosol deposition than air. However, these effects have not been clinically consistent and it is unclear why subjects may or may not respond to the therapy. Here we present 3D-imaging data of aerosol deposition and ventilation distributions from subjects with asthma inhaling He-O2 as carrier gas. The data are compared with those that we previously obtained from a similar group of subjects inhaling air. METHODS: Subjects with mild-to-moderate asthma were bronchoconstricted with methacholine and imaged with PET-CT while inhaling aerosol carried with He-O2. Mean-normalized-values of lobar specific ventilation sV* and deposition sD* were derived and the factors affecting the distribution of sD* were evaluated along with the effects of breathing frequency (f) and regional expansion (FVOL). RESULTS: Lobar distributions of sD* and sV* with He-O2 were not statistically different from those previously measured with air. However, with He-O2 there was a larger number of lobes having sV* and sD* closer to unity and, in those subjects with uneven deposition distributions, the correlation of sD* with sV* was on average higher (p < 0.05) in He-O2 (0.84 ± 0.8) compared with air (0.55 ± 0.28). In contrast with air, where the frequency of breathing during nebulization was associated with the degree of sD*-sV* correlation, with He-O2 there was no association. Also, the modulation of f on the correlation between FVOL and sD*/sV* in air, was not observed in He-O2. CONCLUSION: There were no differences in the inter-lobar heterogeneity of sD* or sV* in this group of mild asthmatic subjects breathing He-O2 compared with patients previously breathing air. Future studies, using these personalized 3D data sets as input to CFD models, are needed to understand if, and for whom, breathing He-O2 during aerosol inhalation may be beneficial.
BACKGROUND: Theoretical models suggest that He-O2 as carrier gas may lead to more homogeneous ventilation and aerosol deposition than air. However, these effects have not been clinically consistent and it is unclear why subjects may or may not respond to the therapy. Here we present 3D-imaging data of aerosol deposition and ventilation distributions from subjects with asthma inhaling He-O2 as carrier gas. The data are compared with those that we previously obtained from a similar group of subjects inhaling air. METHODS: Subjects with mild-to-moderate asthma were bronchoconstricted with methacholine and imaged with PET-CT while inhaling aerosol carried with He-O2. Mean-normalized-values of lobar specific ventilation sV* and deposition sD* were derived and the factors affecting the distribution of sD* were evaluated along with the effects of breathing frequency (f) and regional expansion (FVOL). RESULTS: Lobar distributions of sD* and sV* with He-O2 were not statistically different from those previously measured with air. However, with He-O2 there was a larger number of lobes having sV* and sD* closer to unity and, in those subjects with uneven deposition distributions, the correlation of sD* with sV* was on average higher (p < 0.05) in He-O2 (0.84 ± 0.8) compared with air (0.55 ± 0.28). In contrast with air, where the frequency of breathing during nebulization was associated with the degree of sD*-sV* correlation, with He-O2 there was no association. Also, the modulation of f on the correlation between FVOL and sD*/sV* in air, was not observed in He-O2. CONCLUSION: There were no differences in the inter-lobar heterogeneity of sD* or sV* in this group of mild asthmatic subjects breathing He-O2 compared with patients previously breathing air. Future studies, using these personalized 3D data sets as input to CFD models, are needed to understand if, and for whom, breathing He-O2 during aerosol inhalation may be beneficial.
Authors: Elliot Eliyahu Greenblatt; Tilo Winkler; Robert Scott Harris; Vanessa Jane Kelly; Mamary Kone; Jose Venegas Journal: J Aerosol Med Pulm Drug Deliv Date: 2014-07-22 Impact factor: 2.849
Authors: John P Kress; Imre Noth; Brian K Gehlbach; Nitin Barman; Anne S Pohlman; Annette Miller; Sherwin Morgan; Jesse B Hall Journal: Am J Respir Crit Care Med Date: 2002-05-01 Impact factor: 21.405
Authors: In K Kim; Erin Phrampus; Shekhar Venkataraman; Raymond Pitetti; Al Saville; Timothy Corcoran; Ed Gracely; Nicole Funt; Ann Thompson Journal: Pediatrics Date: 2005-11 Impact factor: 7.124
Authors: E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar Journal: Eur Respir J Date: 2008-01 Impact factor: 16.671
Authors: Rui Carlos Sá; Kirby L Zeman; William D Bennett; G Kim Prisk; Chantal Darquenne Journal: J Aerosol Med Pulm Drug Deliv Date: 2017-03-09 Impact factor: 2.849
Authors: Luciana Alcoforado; Armèle Dornelas de Andrade; Joaquin L Herraiz; Simone Cristina Soares Brandão; Jacqueline de Melo Barcelar; James B Fink; Jose G Venegas Journal: J Aerosol Med Pulm Drug Deliv Date: 2018-04-19 Impact factor: 2.849
Authors: P Worth Longest; Karl Bass; Rabijit Dutta; Vijaya Rani; Morgan L Thomas; Ahmad El-Achwah; Michael Hindle Journal: Expert Opin Drug Deliv Date: 2018-12-10 Impact factor: 6.648